Priority 3 from the Sight Loss and Vision PSP Age Related Macular Degeneration
|
UNCERTAINTY: How can age related macular degeneration (AMD) be prevented? (JLA PSP Priority 3) |
|
|---|---|
| Overall ranking | 3 |
| JLA question ID | 0014a/3 |
| Explanatory note | No relevant systematic reviews identified at the time of the PSP |
| Evidence | No evidence found at the time of the PSP |
| Health Research Classification System category | Eye |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | None provided |
| Systematic reviews that need updating or extending | None identified |
| Systematic reviews in preparation (at time of PSP) | None identified |
| Ongoing controlled trials | Genetics and Markers of Degenerative and Inflammatory Eye Diseases NCT00647439 |
| Submitted by | Patients |
| Outcomes to be measured | Incidence of AMD: change in symptoms; adverse effects or complications; acceptability to the patient; and cost |
| PSP information | |
|---|---|
| PSP unique ID | 0014a |
| PSP name | Sight Loss and Vision - Age Related Macular Degeneration |
| Total number of uncertainties identified by this PSP. | 113 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | April and May 2013 |